Javascript must be enabled to continue!
Ischaemic colitis - review
View through CrossRef
Colonic ischaemia, commonly referred to as ischaemic colitis, is the most common type of intestinal ischaemia. The term "ischaemic colitis" was used by Marston (1966) with three typical patterns of injury described: transient reversible ischaemia, ischaemic ulcers with stricturing, and gangrenous ischaemic colitis. Dominant presenting symptoms were colicky abdominal pain, vomiting, bloody diarrhea, and hematochezia. Patients often have minimal signs on clinical examination. Most patients were diagnosed at colonoscopy. Two regions that are believed to be anatomically vulnerable to ischemic disease are "Griffith?s point", at the splenic flexure and "Sudeck?s critical point", of the Drummond marginal artery. Clinically, ischaemic colitis is classified as non-gangrenous or gangrenous. Non-gangrenous ischaemic colitis involves the mucosa and submucosa and accounts for 80-85 percent of all cases of ischaemic colitis. Non-gangrenous ischaemic colitis is further subclassified into transient, reversible ischaemic colitis with a less severe form of injury and chronic, non-reversible ischaemic colitis, which includes chronic colitis and stricture and has a more severe form of injury. Gangrenous ischaemic colitis accounts for the remaining 15-20 percent of cases and manifests as the most severe form of injury. It includes acute fulminant ischaemia with transmural infarction that may progress to necrosis and death. Specific indications for operation include peritonitis, perforation, recurrent fever or sepsis, clinical deterioration in patients refractory to medical management. Relative indications include fulminant colitis, massive hemorrhage, chronic protein losing colopathy, and symptomatic ischemic structure.
National Library of Serbia
Title: Ischaemic colitis - review
Description:
Colonic ischaemia, commonly referred to as ischaemic colitis, is the most common type of intestinal ischaemia.
The term "ischaemic colitis" was used by Marston (1966) with three typical patterns of injury described: transient reversible ischaemia, ischaemic ulcers with stricturing, and gangrenous ischaemic colitis.
Dominant presenting symptoms were colicky abdominal pain, vomiting, bloody diarrhea, and hematochezia.
Patients often have minimal signs on clinical examination.
Most patients were diagnosed at colonoscopy.
Two regions that are believed to be anatomically vulnerable to ischemic disease are "Griffith?s point", at the splenic flexure and "Sudeck?s critical point", of the Drummond marginal artery.
Clinically, ischaemic colitis is classified as non-gangrenous or gangrenous.
Non-gangrenous ischaemic colitis involves the mucosa and submucosa and accounts for 80-85 percent of all cases of ischaemic colitis.
Non-gangrenous ischaemic colitis is further subclassified into transient, reversible ischaemic colitis with a less severe form of injury and chronic, non-reversible ischaemic colitis, which includes chronic colitis and stricture and has a more severe form of injury.
Gangrenous ischaemic colitis accounts for the remaining 15-20 percent of cases and manifests as the most severe form of injury.
It includes acute fulminant ischaemia with transmural infarction that may progress to necrosis and death.
Specific indications for operation include peritonitis, perforation, recurrent fever or sepsis, clinical deterioration in patients refractory to medical management.
Relative indications include fulminant colitis, massive hemorrhage, chronic protein losing colopathy, and symptomatic ischemic structure.
Related Results
P0100 Role of Ethyl Pyruvate on Large Intestinal Inflammatory and Oxidative Markers in TNBS-Induced Colitis
P0100 Role of Ethyl Pyruvate on Large Intestinal Inflammatory and Oxidative Markers in TNBS-Induced Colitis
Abstract
Background
Ethyl pyruvate (EP), with anti-inflammatory and antioxidant effects, has shown therapeutic potential ...
The Pathophysiology, Presentation and Management of Ischaemic Colitis: A Systematic Review
The Pathophysiology, Presentation and Management of Ischaemic Colitis: A Systematic Review
AbstractThere are currently no guidelines on the long‐term management of patients after an episode of acute ischaemic colitis. Our aim was to review the literature on the pattern o...
Role of Vitamin B17 against Colitis Bearing Female Mice Induced Variations in Some Blood Parameters
Role of Vitamin B17 against Colitis Bearing Female Mice Induced Variations in Some Blood Parameters
Colorectal cancer is also the third most common cause of cancer-related death, and in the US, it ranks as the third most prevalent kind of cancer. The cells that produce mucus to l...
Mycophenolate Mofetil (MMF)-Induced Colitis
Mycophenolate Mofetil (MMF)-Induced Colitis
Abstract
Introduction
MMF is an immunosuppressive drug frequently used for graft-versus-host disease (GVHD) prophylaxis and management. MMF-induced co...
CD8+ Lymphocyte Infiltration is a Specific Feature of Colitis Induced By Immune Checkpoint Inhibitors
CD8+ Lymphocyte Infiltration is a Specific Feature of Colitis Induced By Immune Checkpoint Inhibitors
Abstract
Background
Immune checkpoint inhibitors (ICPIs) have revolutionized cancer therapy, although immune-related adverse events (irAEs) remain a severe issue. The clin...
P0193 Oral administration of Sophora Flavescens-derived exosomes-like nanovesicles carrying CX5461 ameliorates DSS-induced colitis in mice
P0193 Oral administration of Sophora Flavescens-derived exosomes-like nanovesicles carrying CX5461 ameliorates DSS-induced colitis in mice
Abstract
Background
Ulcerative colitis (UC) belongs inflammatory disease with chronic and relapsing characterizations and increa...
P033 Cytomegalovirus colitis: Does concomitant inflammatory bowel disease lead to worse clinical outcomes? Descriptive study from a single-centre experience
P033 Cytomegalovirus colitis: Does concomitant inflammatory bowel disease lead to worse clinical outcomes? Descriptive study from a single-centre experience
BACKGROUND:
The association between cytomegalovirus (CMV) colitis and inflammatory bowel diseases (IBD) is well documented. Current studies estimate a 2% risk of CMV re...
Endotoxemia As Possible Cause of Inflammatory Bowel Diseases-Associated Anemia
Endotoxemia As Possible Cause of Inflammatory Bowel Diseases-Associated Anemia
Inflammatory bowel diseases (IBD), which include Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory conditions of the gastrointestinal tract and highly preva...

